Annual fair welcomed companies including Pfizer, HITS, Amgen, PTL Solar and B.Braun to meet with graduates and outline opportunities within the sector

Dubai, United Arab Emirates. - Sunday, March 29th 2015 [ME NewsWire]

The Dubai Biotechnology and Research Park (DuBiotech), TECOM Investment’s free zone business park dedicated to facilitating the growth of the life sciences industry in the UAE and the Energy and Environment Park (EnPark), TECOM Investment’s free zone dedicated to fostering the alternative energy and environmental industries, yesterday held a career fair where 83 positions were offered to job-seeking students.

The annual event, welcomed 19 leading science-based companies from the region, and internationally, including Pfizer, Amgen, Epygen, HITS, First Solar and B.Braun to showcase their businesses and meet with graduates.

DuBiotech and EnPark are dedicated to fostering the science industries by acting as a bridge between industry, academia and private and public institutions. The annual career fair is just one of a number of initiatives the free zone will host this year as part of its objective of supporting the burgeoning economy and increasing the contribution science makes to the sector.        

The event attracted a diverse mix of attendees, from undergraduate to Masters level students, studying a wide range of disciplines within the science faculty.

Marwan Abdulaziz, Executive Director of TECOM Investment’s DuBiotech and EnPark said, “Facilitating relationships between academia and industry is a crucial part of our ongoing efforts to support the Dubai’s sciences economy. The event is a prime example of our determination to play a key role in the process of developing the industry, offering internships and training opportunities throughout the year.

“The UAE’s science industry has experienced significant growth in recent years. The potential contribution of this sector to the wider economy is significant and to realise this potential, we need to cultivate a highly skilled workforce that positions us to drive the science industry of the future. To do this, it is crucial that we connect students with competitive employment opportunities, to enable us to attract and retain young talent here in the region.”

Ashraf Allam, Vice President, Middle East & Africa, Mundipharma and Chairman of PhRMA regional executive committee commented, “Last year at the DuBiotech and EnPark Career Fair, we took on seven interns to work within our business. Our participation in this event was beneficial experience for both parties as the students gained important work experience, whilst Mundipharma was able to use the opportunity to inject youth into our growing business, and assess the talent on offer for full time employment. As a result, we have implemented the internship programme across the MENA region.”

“This year we are looking to recruit even more interns as we drive growth in our company and help in the bid to bring business and academia much closer together. Mundipharma is always looking to diversify its faculty, drive Emiratisation, and the event here today, hosted by DuBiotech is invaluable role at bringing us closer to the region’s talent.“

As part of the fair Cielo, a leading provider of Recruitment Process Outsourcing (RPO) solutions hold a workshop on resume writing and interview training in order to fully prepare graduates for entering the working world.

- Ends -

Notes to editors:

About DuBiotech

Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments, is a free zone business park dedicated to fostering the growth of the life sciences industry in the region. DuBiotech was established to support the Government of Dubai’s vision to transform the UAE into a knowledge-based economy and develop the region’s talent pool.

DuBiotech offers world-class infrastructure and cutting edge research and development facilities, specifically designed and built for the field of biotechnology, pharmaceutical, medical and scientific device, food and agricultural industries. The free zone can support both start-ups and international firms looking for a regional base for their Middle East or global operations. The park is central to a community that is committed to the industry’s success by bringing together business, regulators and Government in partnership.

Since its launch in 2005, DuBiotech has rapidly grown into a community of more than 200 life sciences companies such as Pfizer, Merck-Serono, Amgen, Bristol-Myers Squibb, Maquet, National Reference Lab, ThermoFisher, Bayer, Mylan, Firmenich and IFF.

For further information on DuBiotech, please visit our website: www.dubiotech.ae.

About EnPark:

EnPark, a member of TECOM Investments, is a free zone dedicated to fostering the growth of the alternative energy and environmental industries, by offering excellent real estate facilities and providing access to the MENA region with a view to helping diversify Dubai’s economy.

EnPark offers businesses technical and community infrastructure facilities across TECOM’s portfolio of business parks promoting industry growth by acting as a bridge between businesses and Government.

As a founding member of the ‘Green Economic Partnership’, a strategic collaboration of Dubai’s leading entities set up accordance with Dubai’s Vision 2021, EnPark is dedicated to facilitating and fostering business growth and encouraging sustainable practices by providing a platform from which companies in the clean tech sector can operate. More than 50 companies, from clean-tech start-ups to energy multinationals, all operate under EnPark’s licences.

Since it was established in 2006, EnPark has been widely recognized for its work and has received a number of high profile awards. In 2012, EnPark was awarded the “UAE Green Brand” and it was honored in the ‘Excellence in Environmental Projects and Products – Future Projects’ category at the Offshore Arabia 2009 Environmental Awards. It was ‘Company of the Year’ at the Alternative Energy Awards in 2008 for its role in raising awareness about sustainability concepts in the region.

Contacts

Iain Munro,

Bell Pottinger

+971 55 559 7389

Permalink: http://me-newswire.net/news/14145/en